Universitätsmedizin, Ernst-Moritz-Arndt-Universität Greifswald
Department of Medicine A
Prof. Dr. Julia Mayerle
Prof. Dr. Markus M. Lerch
Dr. rer. nat. Steffen Teller
The Medical Faculty of Greifswald University (EMAU-G) was established in 1456 and has a strong life sciences record focussed on cancer research and population-based epidemiology (e.g. Study of Health in Pommerania – SHIP). Both of these core programmes are well funded (currently >12Mio €). The Department of Medicine A was ranked number one in the annual research assessment exercise of the University for the last three consecutive years. The department research focus is on pancreatic disorders and currently more than 20 externally funded group members are working in basic or translational pancreas projects. The research of Prof. Lerch and Prof. Mayerle has been continuously funded by the German Research Foundation (DFG), the German Cancer Aid (DKH), the Federal Ministry of Education and Research (BMBF) and several private foundations since 1989. Over 5 years Greifswald University Hospital has established a Pancreas Centre for Northern Germany which initiated, coordinates and currently recruits for the first international multicentre, European phase III trial on chronic pancreatitis (EUROPAC-2) and is the largest continental contributor to the EUROPAC-1 study for patients with hereditary disorders of the pancreas. The second largest German contribution to the ESPAC-3 pancreatic cancer study was recruited in Greifswald. The group has a longstanding expertise in preclinical pancreas research and is internationally established for its expertise in translational projects on pancreatic disorders (5 patent submissions for clinical applications). Cathepsins and their role in pancreatic disorders have been the research focus of both Principal Investigators.